| [1] |
LIU F, LEE S A, XUE J, et al. Global epidemiology of campylobacteriosis and the impact of COVID-19[J]. Front Cell Infect Microbiol, 2022, 12:979055.
|
| [2] |
TIKHOMIROVA A, MCNABB E R, PETTERLIN L, et al. Campylobacter jejuni virulence factors:update on emerging issues and trends[J]. J Biomed Sci, 2024, 31(1):45.
DOI
|
| [3] |
FINSTERER J. Triggers of Guillain-Barré syndrome:Campylobacter jejuni predominates[J]. Int J Mol Sci, 2022, 23(22):14222.
DOI
URL
|
| [4] |
ZHANG D T, ZHANG X, LYU B, et al. Genomic analysis and antimicrobial resistance of Campylobacter jejuni isolated from diarrheal patients-Beijing municipality, China,2019-2021[J]. China CDC Wkly, 2023, 5(19):424-433.
|
| [5] |
GAO F, TU L, CHEN M, et al. Erythromycin resistance of clinical Campylobacter jejuni and Campylobacter coli in Shanghai,China[J]. Front Microbiol, 2023, 14:1145581.
|
| [6] |
BOLINGER H, KATHARIOU S. The current state of macrolide resistance in Campylobacter spp.:trends and impacts of resistance mechanisms[J]. Appl Environ Microbiol, 2017, 83(12):e00416-e00417.
|
| [7] |
QIN S, WANG Y, ZHANG Q, et al. Report of ribosomal RNA methylase gene erm(B)in multidrug-resistant Campylobacter coli[J]. J Antimicrob Chemother, 2014, 69(4):964-968.
|
| [8] |
NOR AMDAN N A, SHAHRULZAMRI N A, HASHIM R, et al. Understanding the evolution of macrolides resistance:a mini review[J]. J Glob Antimicrob Resist, 2024, 38:368-375.
DOI
URL
|
| [9] |
WIECZOREK K, OSEK J. Antimicrobial resistance mechanisms among Campylobacter[J]. Biomed Res Int, 2013, 2013:340605.
|
| [10] |
GIBREEL A, KOS V N, KEELAN M, et al. Macrolide resistance in Campylobacter jejuni and Campylobacter coli:molecular mechanism and stability of the resistance phenotype[J]. Antimicrob Agents Chemother, 2005, 49(7):2753-2759.
DOI
URL
|
| [11] |
CHENG Y, ZHANG W, LU Q, et al. Point deletion or insertion in CmeR-Box,A2075G substitution in 23S rRNA,and presence of erm(B)are key factors of erythromycin resistance in Campylobacter jejuni and Campylobacter coli isolated from central China[J]. Front Microbiol, 2020, 11:203.
DOI
URL
|
| [12] |
赵顺英, 钱素云, 陈志敏, 等. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 新发传染病电子杂志, 2024, 9(1):73-79.
|
| [13] |
LIN J, MICHEL L O, ZHANG Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni[J]. Antimicrob Agents Chemother, 2002, 46(7):2124-2131.
DOI
URL
|
| [14] |
GIBREEL A, TAYLOR D E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli[J]. J Antimicrob Chemother, 2006, 58(2):243-255.
DOI
URL
|
| [15] |
YAO H, SHEN Z, WANG Y, et al. Emergence of a potent multidrug efflux pump variant that enhances Campylobacter resistance to multiple antibiotics[J]. mBio, 2016, 7(5):e01543-16.
|
| [16] |
SHEPPARD S K, MAIDEN M C. The evolution of Campylobacter jejuni and Campylobacter coli[J]. Cold Spring Harb Perspect Biol, 2015, 7(8):a018119.
DOI
URL
|
)
